Clinical Trial Update: The Feasibility Of Expectant Management Versus Induction At 38 Weeks Among Individuals With Gestational Diabetes Mellitus: A Randomized Controlled Pilot Trial (EAGER Pilot Trial) [NA]

View source ↗

Summary

A randomized pilot trial assessing expectant management versus induction at 38 weeks in individuals with gestational diabetes mellitus; the study is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gestational Diabetes Mellitus

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Gestational Diabetes Mellitus (GDM) | NA | Status: RECRUITING